Multiple Sclerosis: From Pathogenesis to Therapy

The Fondation IPSEN, Nature Medicine and Nature Immunology are pleased to announce an Emergence & Convergence mini-symposium: Multiple Sclerosis: From Pathogenesis to Therapy.

Multiple Sclerosis: From Pathogenesis to Therapy June 6, 2008, Espace Charles-Louis-Havas, Paris, France


Registration for this meeting is now closed.

Multiple sclerosis is an inflammatory autoimmune disease targeting the central nervous system, leading to demyelination and axon degeneration and to severe disability as the disease progresses. Multiple sclerosis presents as a clinically heterogeneous disease, which has been problematic for efforts to develop appropriate animal models. Many environmental and genetic factors have been identified that may initiate disease. Various immune and neural cells have been found to play key roles in disease pathogenesis and progression. This Emergence & Convergence mini-symposium will address open questions in multiple sclerosis research, with the goal of identifying future directions that may lead to therapy.

Click here for a free conference poster.

Multiple Sclerosis: From Pathogenesis to Therapy

  • ORGANIZERS

    • Eva Chmielnicki (Nature Medicine, USA)
    • Laurie Dempsey (Nature Immunology, USA)
    • Yves Christen (Fondation IPSEN, France)
  • Date

    June 6, 2008

  • Venue

    Espace Charles-Louis-Havas, Paris, France

    Image: Electron microscope image of demyelination in the lumbar spinal cord of a mouse after experimental autoimmune encephalomyelitis. Image courtesy of Wutian Wu. Image design by Katie Vicari.

Main navigation